|
|
| Line 1: |
Line 1: |
| {{familytree/start |summary=Sample 6}} | | {{familytree/start |summary=Sample 6}} |
| {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | |A01= <div style="float: Center; text-align: Center; width: 20em; padding:1em;"> '''Therapuetic Considerations in [[RVMI]]'''| | | |}} | | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | A01=<div style="float: Center; text-align: Center; width: 20em; padding: 1em;"> ''' All patients with acute inferior wall myocardial infarction ( ST elevation in leads II, III, aVF)'''}} |
| {{familytree | | | | | | | | | | || | |!| | | | | | | | | | | | | | |}}
| |
| {{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}}
| |
| {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}}
| |
| {{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 | |B01='''Reperfusion'''|B02='''Maintenance of RV preload'''|B03='''Decreased RV afterload'''|B04='''Restoring Rate/Rhythm and AV synchrony'''|B05='''Inotropic support'''|B06='''Mechanical Circulatory Support'''}}
| |
| {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | |!| | | |}}
| |
| {{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | |C06 | | |
| |
| |C01=<div style="float: Center; text-align: left; "> •'''Thrmobolytics''' <br> •'''Percutaneous coronary intervention (PCI)''' <br> | |
| |C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload reducing agents''', such as:<br>
| |
| :❑Nitrates
| |
| :❑Diuretics
| |
| :❑Morphin
| |
| • '''In patients with hypotension (without pulmonary congestion):
| |
| :❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain CVP <15mmHg and PCWP between 18-24 mmHg)
| |
| |C03=<div style="float: Center; text-align: left;"> • '''Systemic or pulmonary vasodilators:'''<br>
| |
| :❑Nitrosrusside
| |
| :❑Inhaled nitric oxide<be>
| |
| |C04=<div style="float: Center; text-align: left;"> • '''In patients with bradyarrhthmias:'''<br>
| |
| :❑Atropine
| |
| :❑Pacemaker
| |
| • '''In patients with atrioventricular block:'''<br>
| |
| :❑Temporary dual-chamber pacemaker
| |
| |C05=<div style="float: Center; text-align: left;"> '''In patients with refractory hypotension:'''<br>
| |
| :❑Dobutamine (along with fluids)
| |
| :❑Other inotropes:
| |
| *milrinone
| |
| *norepinephrine
| |
| |C06= <div style="float: Center; text-align: left;"> • '''May be needed in patients with cardiogenic shock secondary to RVMI''':
| |
| :❑Direct RV support
| |
| :❑Indirect RV support
| |
| :❑Biventricular support}}
| |
| <br><br>
| |
| {{familytree/end}} | | {{familytree/end}} |